Filing Details
- Accession Number:
- 0001161697-24-000375
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-23 17:00:13
- Reporting Period:
- 2024-08-21
- Accepted Time:
- 2024-08-23 17:00:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369568 | Catalyst Pharmaceuticals Inc. | CPRX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1292636 | S David Tierney | 355 Alhambra Circle, Suite 801 Coral Gables FL 33134 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2024-08-21 | 15,000 | $4.01 | 363,874 | No | 4 | M | Direct | |
Common Stock, Par Value $0.001 Per Share | Disposition | 2024-08-21 | 15,000 | $20.10 | 348,874 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options to purchase common stock | Acquisiton | 2024-08-22 | 15,000 | $0.00 | 15,000 | $4.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
188,931 | 2025-01-02 | No | 4 | M | Direct |
Footnotes
- Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
- Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $20.00 to $20.485 per share.
- Options vested in three annual tranches beginning on January 2, 2019.